Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma.
| Image |  |
|---|---|
| Description | scientific article published in March 2001 |
| Author/s |
author: Michael J. Boyer |
| Publication date | March 1, 2001 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |